These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 22290952

  • 1. In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.
    Salas V, Pastor FJ, Calvo E, Alvarez E, Sutton DA, Mayayo E, Fothergill AW, Rinaldi MG, Guarro J.
    Antimicrob Agents Chemother; 2012 May; 56(5):2246-50. PubMed ID: 22290952
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A Revised Species Concept for Opportunistic Mucor Species Reveals Species-Specific Antifungal Susceptibility Profiles.
    Wagner L, de Hoog S, Alastruey-Izquierdo A, Voigt K, Kurzai O, Walther G.
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182532
    [Abstract] [Full Text] [Related]

  • 6. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model.
    Sun QN, Najvar LK, Bocanegra R, Loebenberg D, Graybill JR.
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2310-2. PubMed ID: 12069997
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.
    Perkhofer S, Locher M, Cuenca-Estrella M, Rüchel R, Würzner R, Dierich MP, Lass-Flörl C.
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2636-8. PubMed ID: 18458135
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Drug combinations against Mucor irregularis in vitro.
    Zhang S, Li R, Yu J.
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3395-7. PubMed ID: 23587956
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.
    Maurer E, Hörtnagl C, Lackner M, Grässle D, Naschberger V, Moser P, Segal E, Semis M, Lass-Flörl C, Binder U.
    Med Mycol; 2019 Apr 01; 57(3):351-362. PubMed ID: 29924357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.